Skip to main content
. 2020 May 19;57(2):433–444. doi: 10.3892/ijo.2020.5067

Figure 5.

Figure 5

In vitro antitumor efficiencies of different strategies against (A) K-7 and (B) Saos-2 cells after 48 h. (C) Live/death cell dual-staining analysis was performed to evaluate the cytotoxicity of different strategies against K-7 cells after 24 h. *P<0.05; **P<0.01; n=3. CD-CUR, β-cyclodextrin curcumin; DOX, doxorubicin.